EP3329965
SKAMMTAÁÆTLUN FYRIR AND-a4ß7 MÓTEFNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.5.2012EP published:
19.3.2025EP application number:
18150968.8
EP translation filed:
15.4.2025Grant published:
15.5.2025EPO information:
European Patent Register
Max expiry date:
1.5.2032Expiry date:
1.5.2026Next due date:
31.5.2026
Title in English:
DOSING REGIMEN OF ANTI-ALPHA4BETA7-ANTIBODYLanguage of the patent:
English
Timeline
Today
2.5.2012EP application
19.3.2025EP Publication
15.4.2025Translation submitted
15.5.2025Registration published
1.5.2026Expires
Owner
Name:
Millennium Pharmaceuticals, Inc.Address:
40 Landsdowne Street, Cambridge, MA 02139, US
Inventor
Name:
DILUZIO, WillowAddress:
Gloucester, MA 01930, US
Name:
TRUONG, Nobel T.Address:
Milford, MA 01757, US
Name:
VARGA, Csanad M.Address:
Newton, MA 02459, US
Name:
PALANIAPPAN, VaithianathanAddress:
Andover, MA 01810, US
Name:
BROWN, JasonAddress:
Burlington, MA 01803, US
Name:
FOX, Irving H.Address:
Wellesley, MA 02482, US
Name:
SCHOLZ, CatherineAddress:
Woburn, MA 01801, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201161481533 PDate:
2.5.2011Country:
US
Number:
201161550545 PDate:
24.10.2011Country:
US
Number:
201261585859 PDate:
12.1.2012Country:
US
Classification
Categories:
A61P 1/00, A61K 39/395, C07K 16/28, A61K 9/00, A61K 39/00, A61K 9/19, A61K 47/26, A61K 47/18
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 5.5.2025
Expires: 1.5.2026
Payer: Árnason Faktor ehf.